scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Book

Gene Expression: General And Cell-Type-Specific

Michael Karin
TL;DR: This exciting collection of review articles provides a comprehensive introduction to this important area of molecular biology - written by the world's top molecular and cellular biologists.
Patent

Methods for identifying IκB Kinase (IKK) inhibitors

TL;DR: In this paper, the authors present methods and compositions for inhibiting IκB Kinase (IKK) as well as methods for identifying compounds with activity as inhibitors of IKK.
Patent

IKB kinase and methods of using same

TL;DR: A substantially purified nucleic acid molecule encoding a serine protein kinase that phosphorylates a protein (IκB) that inhibits the activity of the NF-κB transcription factor was presented in this paper.
Journal ArticleDOI

P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis

TL;DR: It is demonstrated that SoAT1 participates in hepatocarcinogenesis by increasing cholesterol esterification, thus indicating that SOAT1 is a potential biomarker and therapeutic target in P53-deficient HCC.
Journal ArticleDOI

Common flora and intestine: A carcinogenic marriage

Kepeng Wang, +1 more
- 01 Jan 2013 - 
TL;DR: In this article, the recent advances in understanding the relationship between gut flora and CRC are summarized.